Cargando…
Systematic identification of mutations and copy number alterations associated with cancer patient prognosis
Successful treatment decisions in cancer depend on the accurate assessment of patient risk. To improve our understanding of the molecular alterations that underlie deadly malignancies, we analyzed the genomic profiles of 17,879 tumors from patients with known outcomes. We find that mutations in almo...
Autores principales: | Smith, Joan C, Sheltzer, Jason M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289580/ https://www.ncbi.nlm.nih.gov/pubmed/30526857 http://dx.doi.org/10.7554/eLife.39217 |
Ejemplares similares
-
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
por: Hieronymus, Haley, et al.
Publicado: (2018) -
Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations
por: Nishiyama, Naotaka, et al.
Publicado: (2011) -
MELK expression correlates with tumor mitotic activity but is not required for cancer growth
por: Giuliano, Christopher J, et al.
Publicado: (2018) -
Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab*
por: Price, Timothy J, et al.
Publicado: (2013) -
Characterization of copy number alterations in a mouse model of fibrosis‐associated hepatocellular carcinoma reveals concordance with human disease
por: Chappell, Grace, et al.
Publicado: (2016)